Literature DB >> 11304827

Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder.

T A Greenwood1, M Alexander, P E Keck, S McElroy, A D Sadovnick, R A Remick, J R Kelsoe.   

Abstract

A role for the dopamine transporter (DAT) in bipolar disorder is implicated by several lines of pharmacological evidence, as well as suggestive evidence of linkage at this locus, which we have reported previously. In an attempt to identify functional mutations within DAT contributing a susceptibility to bipolar disorder, we have screened the entire coding region, as well as significant portions of the adjacent non-coding sequence. Though we have not found a definitive functional mutation, we have identified a number of single nucleotide polymorphisms (SNPs) that span the gene from the distal promoter through exon 15. Of the 39 SNPs that are suitable for linkage disequilibrium (LD) studies, 14 have been analyzed by allele-specific PCR in a sample of 50 parent-proband triads with bipolar disorder. A haplotyped marker comprised of five SNPs, spanning the region between exon 9 and exon 15, was constructed for each individual, and transmission/disequilibrium test (TDT) analysis revealed this haplotype to be in linkage disequilibrium with bipolar disorder (allele-wise TDT p = 0.001, genotype-wise TDT p = 0.0004). These data replicate our previous finding of linkage to markers within and near DAT in a largely different family set, and provide further evidence for a role of DAT in bipolar disorder. Published 2001 Wiley-Liss. Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304827     DOI: 10.1002/1096-8628(2001)9999:9999<::aid-ajmg1161>3.0.co;2-8

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  42 in total

1.  Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.

Authors:  Epolia Ramadan; Mireille Basselin; Ameer Y Taha; Yewon Cheon; Lisa Chang; Mei Chen; Stanley I Rapoport
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

2.  Association of TPH1 with suicidal behaviour and psychiatric disorders in the Chinese population.

Authors:  X Liu; H Li; W Qin; G He; D Li; Y Shen; J Shen; N Gu; G Feng; L He
Journal:  J Med Genet       Date:  2006-02       Impact factor: 6.318

3.  A linkage and family-based association analysis of a potential neurocognitive endophenotype of bipolar disorder.

Authors:  Jonathan Savitz; Lize van der Merwe; Mark Solms; Rajkumar Ramesar
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

4.  Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots.

Authors:  Oleg Kovtun; Ian D Tomlinson; Dhananjay S Sakrikar; Jerry C Chang; Randy D Blakely; Sandra J Rosenthal
Journal:  ACS Chem Neurosci       Date:  2011-04-26       Impact factor: 4.418

Review 5.  The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.

Authors:  Jordy van Enkhuizen; David S Janowsky; Berend Olivier; Arpi Minassian; William Perry; Jared W Young; Mark A Geyer
Journal:  Eur J Pharmacol       Date:  2014-08-05       Impact factor: 4.432

6.  Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.

Authors:  Tiffany A Greenwood; Eun-Jeong Joo; Tatyana Shekhtman; A Dessa Sadovnick; Ronald A Remick; Paul E Keck; Susan L McElroy; John R Kelsoe
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-12-19       Impact factor: 3.568

7.  Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.

Authors:  C Dong; M-L Wong; J Licinio
Journal:  Mol Psychiatry       Date:  2009-10-20       Impact factor: 15.992

8.  GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.

Authors:  Jared W Young; Andrew K L Goey; Arpi Minassian; William Perry; Martin P Paulus; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2009-12-18       Impact factor: 4.530

9.  Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice.

Authors:  Susan B Powell; Jared W Young; Jacob C Ong; Marc G Caron; Mark A Geyer
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

10.  Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder.

Authors:  Richard C McEachin; Nancy L Saccone; Scott F Saccone; Yelena D Kleyman-Smith; Tiara Kar; Rajesh K Kare; Alex S Ade; Maureen A Sartor; James D Cavalcoli; Melvin G McInnis
Journal:  BMC Med Genet       Date:  2010-01-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.